Age‐Associated Variations in Complete Blood Cell Count Parameters and Derived Indices Among Community‐Dwelling Chinese Older Adults Authors: Xiangyi Ma, Na Liu, Xiang Wu, Qiudan Chen, Xiaotong Chen, Qingyu Zhou, Shuying Chen, Yong Lin, Xuefeng Wang Published: 2026 ABSTRACT ABSTRACTBackgroundThis study aims to systematically characterize the physiological trajectories of complete blood cell count (CBC) parameters and their derived inflammatory indicators with age, providing high‐quality evidence for assessing immunosenescence and the health of the elderly.MethodsThis cross‐sectional study initially recruited 9331 participants aged 24–97 years. After applying exclusion criteria, 1630 healthy individuals were included for analysis. Data are presented as median (2.5th–97.5th percentiles). The Kruskal–Wallis test followed by Dunn's test with Bonferroni correction was used to compare CBC parameters and their derived indicators among four age groups within each sex. The Mann–Whitney U test was used to compare differences between males and females within each age group.ResultsRed blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), and mean corpuscular hemoglobin concentration (MCHC) decreased with age, while mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red blood cell distribution width (RDW‐CV) increased; sex‐specific differences persisted in most parameters. Monocyte percentage and absolute count gradually increased with age; other white blood cell differentials showed variable patterns. Among CBC derived indicators: PLR and SII decreased with age; MLR remained low with limited variability in males; NLR exhibited a fluctuating trend across age groups. Platelet (PLT) progressively decreased with age.ConclusionThe comprehensive dataset generated in this study has allowed observation of dynamic profiles of CBC parameters and their derived indicators in the healthy elderly population. This provides scientific evidence and theoretical support for aging and health assessment as well as chronic disease management among older adults. Introduction With the accelerating aging of China's population, the associated health challenges are becoming increasingly prominent. Statistics show that although life expectancy among the elderly has significantly increased, healthy lifespan has not kept pace. Many older adults live with chronic conditions for extended periods, and multi‐morbidity is prevalent, severely compromising their quality of life. Research indicates that aging is the greatest risk factor for the majority of chronic diseases [1]. Therefore, understanding the intrinsic link between aging and chronic diseases, and exploring blood biomarker changes during aging, are crucial for early identification of high‐risk individuals and prevention of age‐related diseases. Aging is a complex biological process, and various hallmarks of aging are interconnected and intricately linked. Researchers have proposed three criteria that apply for hallmark of aging, one of which is age‐associated manifestation [2]. Complete blood cell count (CBC), a routine and readily available clinical test, provides parameters and derived inflammatory indicators (NLR, PLR, MLR, SII) that not only reflect hematopoietic and immune inflammatory state but have also been proven to be closely associated with a range of age‐related conditions and adverse outcomes, including cardiovascular and cerebrovascular diseases, cancer, depression and frailty [3, 4, 5, 6, 7, 8, 9]. This study aims to systematically depict the physiological trends of CBC parameters and their derived inflammatory indicators throughout the aging process, providing high‐quality evidence for assessing the hematopoietic and immune‐inflammatory status as well as the health of the elderly. Materials and Methods Study Population This cross‐sectional study was supported by the National Key Research and Development Program of China. To characterize the age‐related changes in CBC parameters and their derived indicators in relatively healthy older adults, we recruited 9331 volunteers from Youyi Community and Jiangchuan Community in Shanghai. Exclusion criteria were the following: Physical information: presence of diabetes, hypertension; severe heart failure, liver failure, kidney failure, or respiratory failure; malignant tumors; severe allergies or autoimmune diseases; hematological disorders; history of transplantation, recent surgery (within 1 month), or blood transfusion (within 4 months); acute or chronic infections; pregnancy or delivery within the past year; and abnormal specimens such as lipidemia, jaundice, or hemolysis. Laboratory indicators: fasting glucose ≥ 7.0 mmol/L; total cholesterol ≥ 6.2 mmol/L; triglycerides ≥ 2.3 mmol/L. Questionnaire information: systolic blood pressure (SBP) ≥ 140 mmHg and diastolic blood pressure (DBP) ≥ 90 mmHg; body mass index (BMI) ≥ 28 or ≤ 18; Mini‐Mental State Examination (MMSE) < 25; Activities of Daily Living (ADL) < 100; Geriatric Depression Scale (GDS) ≥ 5. After exclusion, samples from 1630 participants were included in this study (Figure 1), with 699 males and 931 females stratified into four age groups at 10‐year intervals: < 60, 60–69, 70–79, and ≥ 80 years. The sample sizes for each age‐sex subgroup are presented in Table 2. This stepwise selection process was designed to minimize confounding from common age‐related diseases, enabling us to characterize the physiological trajectories of hematological parameters during healthy aging. Flowchart of the sample selection. We recruit 9331 participants from Youyi and Jiangchuan Community. A total of 2721 samples with missing data were removed, and another 4534 were excluded based on laboratory criteria. The final analytical cohort consisted of 1630 subjects selected from the remaining 2076 samples using the MMSE, GDS, and ADL criteria. Standardization and Assurance of Quality Control This study implemented strict quality control and standardized procedures throughout the entire process. Before sample collection, all phlebotomists must receive standardized training to ensure uniformity in both procedural techniques and venous compression time. Blood samples were collected using EDTA‐anticoagulated tubes from a single manufacturer to maintain sample consistency. After sample collection, all samples were transported to the laboratory within 2 h at room temperature and analyzed within a total of 4 h, effectively preventing cell morphology changes and result drift. All testing procedures were conducted using the same automated blood analyzer (Sysmex XN‐1000; Sysmex Corporation, Kobe, Japan), which was regularly calibrated and strictly adhered to standard operating procedures. Daily internal quality control is conducted to ensure the precision and accuracy of the instrument remain within acceptable parameters. This standardized operational protocol significantly minimizes pre‐analytical and analytical variability, thereby ensuring robust validity and comparability of the research findings. CBC‐Derived Inflammatory Indicators We computed the NLR, PLR, MLR, and SII using the following formulas: NLR=neutrophil counts/lymphocyte counts PLR=platelet counts/lymphocyte counts MLR=monocyte counts/lymphocyte counts SII=platelet counts×neutrophil counts/lymphocyte counts Statistical Analysis Data analysis was performed using SPSS 26.0. Due to non‐normal distribution (assessed by the Shapiro‐Wilson test), continuous variables were expressed as median (P2.5–P97.5). For comparisons among the four age groups within each sex, the Kruskal–Wallis test was used, followed by Dunn's test with Bonferroni correction for post hoc pairwise comparisons. p value < 0.05 was considered statistically significant. Differences between males and females within the same age group were evaluated using the Mann–Whitney U test. p value < 0.05 was considered statistically significant. Boxplots showing the median and the 2.5th–97.5th percentiles were used to visualize the distribution of CBC parameters and their derived indicators across age and sex subgroups, with statistical significance for comparisons between sexes within each age group indicated in the figures. Results After applying the exclusion criteria, a total of 1630 individuals (699 males and 931 females) were included in the study. Participants were divided into four age groups at 10‐year intervals: < 60, 60–69, 70–79, and ≥ 80 years. The characteristics of the total population and each age subgroup are presented in Table 1. Table 2 and Table S1 present the median and the 2.5th–97.5th percentile values for each hematological parameter, stratified by age group and sex, and also present comparisons between the four age groups separately for males and females. Figure 2 and Figure S1–S3 illustrate the trends of CBC parameters and their derived indicators across the four age groups, with comparisons between males and females within each age group. TABLE 1Characteristics of the study population.CharacteristicsTotalAge range, years p a < 6060–6970–79≥ 80No. individuals1630180701612137Age, years69 (44, 84)50 (30, 59)66 (60, 69)73 (70, 79)83 (80, 92)< 0.001Sex, %Male42.98.942.949.856.2Female57.191.157.150.243.8BMI, kg/m2 23.5 (18.9, 27.5)23.4 (19.1, 27.3)23.7 (19.0, 27.5)23.4 (18.8, 27.5)23.2 (18.7, 27.4)0.259MMSE28.0 (25.0, 30.0)27.0 (25.0, 30.0)28.0 (25.0, 30.0)28.0 (25.0, 30.0)27.0 (25.0, 30.0)< 0.001GDS1.0 (0.0, 4.0)2.0 (0.0, 4.0)0.0 (0.0, 4.0)1.0 (0.0, 4.0)1.0 (0.0, 4.0)< 0.001ADL100 (100, 100)100 (100, 100)100 (100, 100)100 (100, 100)100 (100, 100)1.000MNA25.5 (21.0, 28.0)25.5 (21.0, 28.0)25.5 (21.5, 28.5)25.5 (21.1, 28.3)25.0 (19.7, 28.0)0.007SBP, mmHg128 (103, 138)121 (100, 136)128 (104, 138)128 (102, 139)130 (107, 138)< 0.001DBP, mmHg76 (60, 87)75 (59, 88)77 (62, 88)76 (60, 86)76 (55, 84)0.005 Note: Data are presented as median (P2.5–P97.5).Abbreviations: ADL, activity of daily living scale; BMI, body mass index; DBP, diastolic blood pressure; GDS, the geriatric depression scale; MMSE, mini‐mental state examination; MNA, mini nutritional assessment; SBP, systolic blood pressure. a Kruskal–Wallis test for comparisons 4 age groups (p < 0.05 was considered statistically significant). Characteristics of the study population. Note: Data are presented as median (P2.5–P97.5). Abbreviations: ADL, activity of daily living scale; BMI, body mass index; DBP, diastolic blood pressure; GDS, the geriatric depression scale; MMSE, mini‐mental state examination; MNA, mini nutritional assessment; SBP, systolic blood pressure. Kruskal–Wallis test for comparisons 4 age groups (p < 0.05 was considered statistically significant). TABLE 2Age‐and‐sex specific distributions of CBC and its derived inflammatory parameters M (P2.5–P97.5).AnalyteAge range, yearsMaleFemaleSamples, n Med (P2.5–P97.5)Samples, n Med (P2.5–P97.5)RBC, ×1012/L a < 60165.1 (4.6, 5.7)c,d 1644.5 (3.9, 5.3)c,d 60–693014.9 (4.0, 5.7)c,d 4004.4 (3.8, 5.3)c,d 70–793054.7 (3.8, 5.5)a,b,d 3074.3 (3.6, 5.0)a,b,d ≥ 80774.5 (3.8, 5.8)a,b,c 604.2 (3.1, 5.2)a,b,c HGB, g/L a < 6016158 (145, 218)c,d 164135 (94, 157)d 60–69301153 (128, 170)c,d 400136 (115, 152)c,d 70–79305148 (121, 171)a,b,d 307133 (113, 151)b,d ≥ 8077142 (113, 167)a,b,c 60127 (107, 145)a,b,c HCT, % a < 601646.4 (43.0, 50.2)d 16441.0 (31.3, 46.2)b,d 60–6930146.1 (39.2, 52.7)c,d 40042.0 (36.0, 48.1)a,c,d 70–7930545.0 (37.3, 51.5)b,d 30741.0 (35.3, 46.6)b,d ≥ 807743.5 (34.1, 51.1)a,b,c 6039.8 (33.3, 46.5)a,b,c WBC, ×109/L< 60165.8 (4.0, 8.3)1645.2 (3.4, 7.8)60–693016.1 (3.7, 8.9)4005.3 (3.4, 8.3)70–793055.9 (3.7, 9.1)3075.4 (3.3, 8.6)≥ 80775.8 (3.7, 9.9)605.7 (3.0, 9.8)NEUT, % a < 601661.2 (49.1, 68.6)d 16461.6 (47.1, 73.9)b,c,d 60–6930154.9 (38.1, 70.2)40056.9 (39.7, 72.6)a 70–7930556.9 (39.7, 72.6)30755.8 (38.1, 73.3)a ≥ 807754.6 (39.2, 67.3)a 6056.4 (44.3, 73.9)a LYMPH, % a < 601629.4 (20.9, 36.8)16430.9 (18.7, 45.5)b,c,d 60–6930133.5 (20.0, 50.7)40036.4 (21.6, 51.6)a,c,d 70–7930532.6 (17.2, 50.7)30734.2 (19.8, 52.7)a,b ≥ 807734.3 (20.4, 50.3)6032.5 (17.0, 45.3)a,b MONO, % a < 60165.9 (4.1, 9.2)d 1645.4 (3.3, 8.1)b,c,d 60–693016.8 (4.1, 10.4)d 4006.2 (3.6, 10.4)a,d 70–793057.2 (4.1, 12.0)3076.5 (4.0, 10.6)a,d ≥ 80777.7 (4.8, 11.8)a,b 607.4 (3.8, 12.3)a,b,c EO,% b < 60162.0 (0.8, 13.5)1641.2 (0.2, 5.7)b,c,d 60–693012.3 (0.5, 9.8)4001.6 (0.4, 6.1)a 70–793052.2 (0.4, 8.8)3071.7 (0.4, 8.2)a ≥ 80772.3 (0.4, 10.7)601.9 (0.6, 5.3)a BASO, % b < 60160.4 (0.2, 0.8)1640.4 (0.1, 1.1)b,c,d 60–693010.5 (0.1, 1.1)4000.4 (0.2, 1.1)a 70–793050.5 (0.1, 1.2)3070.5 (0.1, 1.0)a ≥ 80770.4 (0.1, 1.3)600.5 (0.0, 1.3)a PLT, ×109/L a < 6016219 (137, 305)c,d 164256 (168, 371)b,c,d 60–69301203 (119, 329)c,d 400216 (125, 330)a 70–79305190 (113, 295)a,b 307209 (107, 317)a ≥ 8077173 (106, 262)a,b 60197 (89, 342)a Note: Within each sex, post hocpairwise comparisons among age groups were performed using Dunn's test with Bonferroni correction. Different superscript letters (a‐d) indicate significant differences between age groups (corrected p < 0.05): a p < 0.05 vs. < 60 age group; b p < 0.05 vs. 60–69 age group; c p < 0.05 vs. 70–79 age group; d p < 0.05 vs. ≥ 80 age group.Abbreviations: BASO, basophil percentage; EO, eosinophil percentage; HCT, hematocrit; HGB, hemoglobin; LYMPH, lymphocyte percentage; MONO, monocyte percentage; NETU, neutrophil percentage; PLT, platelet counts; RBC, red blood cell counts; WBC, white blood cell counts. a Parameters marked with this symbol showed statistically significant differences across age groups in both males and females (Kruskal–Wallis test, p < 0.05). b Parameters marked with this symbol showed statistically significant differences across age groups in females only (Kruskal–Wallis test, p < 0.05). Age‐and‐sex specific distributions of CBC and its derived inflammatory parameters M (P2.5–P97.5). Note: Within each sex, post hocpairwise comparisons among age groups were performed using Dunn's test with Bonferroni correction. Different superscript letters (a‐d) indicate significant differences between age groups (corrected p < 0.05): a p < 0.05 vs. < 60 age group; b p < 0.05 vs. 60–69 age group; c p < 0.05 vs. 70–79 age group; d p < 0.05 vs. ≥ 80 age group. Abbreviations: BASO, basophil percentage; EO, eosinophil percentage; HCT, hematocrit; HGB, hemoglobin; LYMPH, lymphocyte percentage; MONO, monocyte percentage; NETU, neutrophil percentage; PLT, platelet counts; RBC, red blood cell counts; WBC, white blood cell counts. Parameters marked with this symbol showed statistically significant differences across age groups in both males and females (Kruskal–Wallis test, p < 0.05). Parameters marked with this symbol showed statistically significant differences across age groups in females only (Kruskal–Wallis test, p < 0.05). Comparison of blood parameters RBC, HGB, HCT, WBC, and PLT between males and females across different age groups. Data are presented as box‐and‐whisker plots. The line inside each box represents the median, the box spans the interquartile range (IQR), and the whiskers extend to the 2.5th and 97.5th percentiles. Sex differences within each age group were assessed using the Mann–Whitney U test. Significance levels are indicated as follows: ***p < 0.001, **p < 0.01, *p < 0.05, ns, not significant. Age‐Related Changes of Erythroid‐Related Parameters The distributions of erythroid‐related parameters across age groups and sexes are presented in Table 2, Figure 2b,d,e and Figure S1. Red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), and mean corpuscular hemoglobin concentration (MCHC) levels exhibited a gradual decline with advancing age, whereas mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red blood cell distribution width (RDW‐CV) showed a progressive increase. Sex‐specific differences persisted in most parameters, with the trajectories of age‐related changes exhibiting distinct characteristics between males and females. RBC, HGB, HCT, and MCHC levels were significantly higher in males than in females across all age groups (p < 0.001, Figure 2b,d,e and Figure S1). Notably, the patterns of age‐related changes in these parameters differed between males and females. Taking HGB as an example, from the < 60 years group to the ≥ 80 years group, the median value in males decreased from 158 to 142 g/L (a reduction of 16 g/L). In contrast, females only decreased from 135 to 127 g/L (a reduction of 8 g/L). Consequently, the sex gap in HGB narrowed from 23 g/L in the < 60 years group to 15 g/L in the ≥ 80 years group, suggesting that the age‐related decline in erythroid hematopoietic function may be more rapid in males than in females (Table 2). MCHC levels showed a decreasing trend with age, with a more pronounced decline observed between the < 60 and 60–69 years groups (Table 2). In contrast to the aforementioned parameters, MCV, MCH, and RDW‐CV exhibited an increasing trend with age (Table 2, Figure S1). Levels of MCV showed a pronounced elevation during the transition from the < 60 to the 60–69 years group. In comparison, RDW‐CV levels demonstrated significant increases during both the < 60 to 60–69 years and 70–79 to ≥ 80 years transitions, reflecting a progressive increase in the heterogeneity of red blood cell volume during the aging process (Table 2). Although MCV and RDW‐CV increased with age, the trajectories for males and females were essentially parallel, with no significant sex differences observed within each age group (Figure S1). Significant sex differences in MCH were observed in the four age groups, with males having consistently higher levels than females (Figure S1). Age‐Related Changes in Leukocyte‐Associated Parameters and PLT Platelet (PLT) parameters showed a constant decline with age. In contrast to RBC parameters, platelet parameters were consistently higher in females than in males across all four age groups, and these sex differences were statistically significant (Table 2, Figure 2c). The distributions of leukocyte‐associated parameters across age groups and sexes are presented in Table 2, Table S1, Figures 2a and Figure S2. White blood cell counts (WBC) showed a fluctuating pattern with age in males, whereas a gradual upward trend was observed in females (Figure 2a). When comparing males and females within each age group, statistically significant differences were observed in the 60–69 and 70–79 age groups (Mann–Whitney U test, p < 0.001). However, within each sex, no statistically significant differences were observed across the four age groups (Table 2). For neutrophil percentage (NEUT%), a marked decrease was observed between the < 60 and 60–69 age groups in both sexes (Figure S2a). For lymphocyte percentage (LYMPH%), a rapid increase was observed between the < 60 and 60–69 age groups in both sexes (Figure S2b). In males, the Kruskal–Wallis test showed a significant overall difference across age groups (p = 0.020); however, after Bonferroni correction for multiple comparisons, no significant pairwise differences were identified, although the comparison between the < 60 and ≥ 80 age groups approached significance (adjusted p = 0.052). In contrast, females showed statistically significant differences across the four age groups (Table 2). For monocyte percentage (MONO%) and absolute count, both parameters showed an increasing trend with age. Notably, statistically significant sex differences were observed across the first three age groups (Table 2, Table S1 and Figure S2c,h). For eosinophils (EO) and basophils (BASO), no statistically significant differences were observed across age groups in males, whereas females showed differences across the four age groups (Table 2, Table S1). However, the differences between males and females were not substantial (Figure S2). Age‐Related Changes in Leukocyte Derived Inflammatory Indicators We analyzed the age‐related trajectories of four WBC‐derived inflammatory indicators in this study (Figure S3). The trend of NLR was similar to that of NEUT%, showing a sharp decrease from the < 60 to the 60–69 age group, a slight increase from the 60–69 to the 70–79 age group, and divergent sex thereafter—females exhibited a continued upward trend, whereas males showed a downward trend. PLR and SII, both indicators, decreased with age; notably, PLR values were significantly higher in females than in males across all four age groups (Figure S3). MLR values remained low with limited variability in males, whereas a slight increasing trend with age was observed in females. Statistically significant differences across the four age groups were observed for both sexes in all four indicators (Table S1). Discussion Our study systematically revealed the age‐related characteristics of complete blood cell count and its derived indicators through cross‐sectional analysis of 1630 healthy elderly individuals. These changes in haematological parameters reflect the physiological alterations that occur during the aging process. The key findings include: RBC, HGB, HCT, and MCHC decreased with age, while MCV, MCH, and RDW‐CV increased; sex‐specific differences persisted in most parameters. Monocyte percentage and absolute count gradually increased with age; other white blood cell differentials showed variable patterns. Among derived indices: PLR and SII decreased with age, with PLR significantly higher in females across all age groups; MLR remained low with limited variability in males while showing a slight increase in females; NLR exhibited a fluctuating trend across age groups. PLT progressively decreased with age, with consistently higher values in females than in males. The trends of erythroid parameters with age observed in this study are consistent with the results of a previous study [10]. HGB levels exhibit variations influenced by both age and sex, likely due to the effect of androgen in stimulating erythropoietin production and the cessation of menstrual blood loss in old women. These results indicate that even in healthy elderly populations, there exists age‐related mild hematopoietic decline or reduced erythropoietic capacity. As stated by previous research, the prevalence of asymptomatic and mild anemia increased in apparently healthy older adults supports the view that the decline in HGB levels might be a consequence of normal aging [10, 11, 12]. Our analysis also demonstrated significant sex differences in RBC levels across age groups, with males showing more pronounced decreases than females. However, these gender disparities gradually diminish with advancing age. In a recent publication, Zhou et al. [13] observed sex‐specific differences in the trajectories of erythroid parameters during aging, with males exhibiting a more pronounced decline in RBC counts. The authors propose that this phenomenon is attributable to a significantly higher mtDNA content within male RBCs. Elevated mtDNA in RBCs promotes oxidative stress, leading to damage to the cell membrane and inducing apoptosis [14]. This, in turn, accelerates RBC senescence and ultimately results in a reduced RBC count. Thus, mtDNA content may be one of the mechanisms underlying RBC aging and the faster physiological decline observed in males. Analysis of the research data reveals that MCV and RDW parameters increase with age. RDW is a measure of the heterogeneity of circulating red blood cell volume. A higher RDW value reflects greater anisocytosis. Research indicates that even within normal reference ranges, elevated RDW is closely associated with increased risks of mortality and cardiovascular events in the elderly and this association remains independent of factors such as anemia, nutritional status, inflammation, and age‐related diseases [15]. Given its association with aging and age‐related diseases, RDW can serve as a biomarker reflecting multiple physiological impairments with aging [16, 17, 18]. Currently, the biological mechanisms underlying the association between increased RDW, aging and mortality remain unclear. However, some studies suggest that oxidative stress and chronic inflammation may be involved. The study by Huibert et al. [19] suggested that oxidative stress‐induced alterations in red blood cell size could be a driving factor for elevated RDW. Relevant in vitro experiments showed that oxidative stress induces red blood cell membrane damage, increasing cell rigidity, reducing deformability, decreasing cell volume, and ultimately leading to increased erythrocyte heterogeneity. The age‐related trends in leukocyte parameters likely reflect the overall immune‐inflammatory status in older adults. A comparison with previous studies [20, 21] that highlight existing discrepancies in our findings, notably in WBC, LYMPH%, and MONO%. The reasons for these discrepancies remain unclear but may be related to differences in the study populations and age stratification. In terms of gender differences, both our study and prior research consistently observed differences in leukocyte parameters between males and females. Existing evidence indicates that estrogen can stimulate immune responses, whereas testosterone tends to suppress the response to infection [22], which may partly explain these sex‐based differences. However, some studies suggest that despite the observed disparities, their magnitude may be too small to be of clinical significance [21]. It is clear from our study that the total white blood cell and monocyte counts demonstrated the most significant age‐related increase. Aging induces alterations in both the number and function of innate immune cells, with these changes mainly concentrated in myeloid cells, such as neutrophils, monocytes/macrophages, etc. This phenomenon may be attributed to the aging‐related bias of hematopoietic stem cells toward myeloid differentiation [23]. Aging is a highly complex physiological and pathological process, and the associated changes within the immune system are termed immunosenescence [24]. Monocytes are recognized as immune effector cells, participating in the innate immune response, secreting pro‐inflammatory cytokines and antigen presentation [25]. Observational studies [26] have revealed that in older adults, both the number and function of monocytes vary with frailty status. Notably, frail elderly individuals exhibit increased monocyte counts. Among leukocyte‐derived inflammatory markers, the MLR kept constant without differences in sex and age, while the PLR and SII demonstrated declining trends. NLR demonstrated a fluctuating trend over time. This trend contrasts with the conventional view that aging is accompanied by elevated inflammatory markers, highlighting the complexity of immunosenescence. The observed fluctuation in the NLR could be attributable to a relative stability in neutrophil counts in older individuals. Conversely, the decreases in the PLR and SII likely reflect the age‐related reduction in lymphocyte and platelet counts, suggesting that the bone marrow hematopoietic microenvironment and megakaryopoiesis are also impacted by aging. Our analysis suggests that these trends result from the combined effect of multiple factors. In agreement with a previous study on platelet count, we observed that there is a negative correlation between platelets and age as well as slightly higher counts in adult women compared to men [27, 28]. This age‐related decrease in platelet count may be related to the decline in the function of hematopoietic stem cells. Hematopoietic stem cells sustain the stable generation of various blood cells through multi‐lineage differentiation. With advancing age, the functioning of aged HSCs is impaired, including a declined repopulation capacity and myeloid and platelet‐restricted differentiation, which may lead to a decline in platelet count [29]. In platelet‐related diseases, the prevalence of thrombocytosis progressively decreased with age, and in contrast, the prevalence of thrombocytopenia increased with age, which trends to be more frequent among the elderly [30]. Women had slightly higher counts than men that may be related to hormonal factors. According to reports, megakaryocytes proceed to proplatelet formation and platelet production and are under the influence of autocrine estrogen. Additionally, estrogen‐receptor antagonists inhibit platelet production, supporting a role of estrogens in platelet production [28, 31, 32]. Platelets not only play a pivotal role in hemostasis and thrombosis but are also recognized as inflammatory cells or a source of inflammatory mediators. Furthermore, during the process of atherothrombosis, platelets can be activated by several inflammatory triggers, thereby actively contributing to the disease process [33]. In conclusion, we found the trends of CBC parameters and derived inflammatory indicators with respect to age and sex in healthy older adults. The study has notable strengths. First, we adhered to key principles of clinical laboratory guidelines throughout the research process: rigorous exclusion criteria were applied to ensure a relatively healthy study population; all blood samples were collected and processed using standardized protocols, and analysis was completed within 4 h of collection using an analyzer (Sysmex XN‐1000) with daily internal quality control; and given the non‐normal distribution of hematological parameters, data were summarized using medians with 2.5th and 97.5th percentiles—a robust nonparametric approach for describing skewed data. These methodological practices ensure the reliability and robustness of our findings, providing a solid foundation for future research aimed at developing health assessment models for aging populations. Additionally, the large sample size from a community‐dwelling population provides reliable data on the distribution of CBC parameters and their derived indicators. Our analysis, stratified by age and sex, offers preliminary insights into the physiological variations of these parameters, which may lay a groundwork for future studies to develop health assessment models for aging populations and to assess their applicability. Despite these findings, several limitations of our study should be considered. First, the cross‐sectional nature of our study precludes any causal inferences regarding the observed associations. Second, although we had a relatively large sample size from a community‐based population, which enhances the generalizability of our findings to the general public compared to hospital‐based studies, potential selection bias cannot be entirely ruled out as participants might be more health‐conscious. Third, information on certain potential confounders, such as detailed dietary habits, recent subclinical infections, and physical activity levels, was not available, which might have led to residual confounding. Fourth, the exclusion of participants with acute or chronic infections was based on clinical assessment rather than objective inflammatory biomarkers such as C‐reactive protein. While this approach helped exclude overt infections, it may not have fully captured low‐grade inflammation, which is common in aging populations and may influence CBC parameters. Future studies incorporating sensitive inflammatory markers are warranted to enable more accurate identification and exclusion of individuals with low‐grade inflammation, thereby improving the reliability of the CBC results. Funding This work was supported by grants from Shanghai Municipal Health Commission (GWVI‐11.1‐27; Y.L.) and National Key Research and Development Plan of China (2018YFC2000200; Y.L.). Conflicts of Interest The authors declare no conflicts of interest. Supporting information Table S1: Age‐and‐sex specific distributions of CBC and other derived inflammatory parameters M (P2.5–P97.5). Figure S1: Comparison of blood parameters MCV, MCH, MCHC and RDW‐CV between males and females across different age groups. Figure S2: Comparison of blood parameters NEUT%, LYMPH%, MONO%, EO%, BASO%, NEUT#, LYMPH#, MONO#, EO#, and BASO# between males and females across different age groups. Figure S3: Comparison of blood parameters NLR, MLR, PLR, and SII between males and females across different age groups.